Computational Approach Towards Exploring Potential Anti-Chikungunya Activity of Selected Flavonoids

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Seyedi, Seyedeh Somayeh ^a   Shukri, Munirah ^a   Hassandarvish, Pouya ^a   Oo, Adrian ^a   Muthu, Shankar Esaki ^a   Abubakar, Sazaly ^a   Zandi, Keivan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BAICALIN; CHROMONE DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOID; NARINGENIN; PROTEIN BINDING; QUERCETAGETIN; VIRAL PROTEIN;

BINDING SITE; CHEMISTRY; CHIKUNGUNYA VIRUS; METABOLISM; MOLECULAR DOCKING;

ANTIVIRAL AGENTS; BINDING SITES; CHIKUNGUNYA VIRUS; CHROMONES; FLAVANONES; FLAVONOIDS; MOLECULAR DOCKING SIMULATION; PROTEIN BINDING; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84963968554     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24027     Document Type: Article

References (38)

1. Parashar, D. & Cherian, S. Antiviral perspectives for chikungunya virus. BioMed Res. Int. 2014, 1-11 (2014).
2. Voss, J. E. et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature. 468, 709-712 (2010)
3. Ahola, T. et al. Therapeutics and vaccines against chikungunya viruses. Vector-borne zoonotic Dis. 15, 250-257 (2015).
4. Kaur, P. et al. Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression. Antimicrob. Agents. 57, 155-167 (2013).
5. Rathee, P. et al. Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm. Allergy Drug Targets. 8, 229-235 (2009).
6. Brunetti, C., Di Ferdinando, M., Fini, A., Pollastri, S. & Tattini, M. Flavonoids as antioxidants and developmental regulators: relative significance in plants and humans. Int. J. Mol. Sci. 14, 3540-3555 (2013).
7. Orhan, D. D., Ozcelik, B., Ozgen, S. & Ergun, F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol. Res. 165, 496-504 (2010).
8. Hendra, R., Ahmad, S., Sukari, A., Shukor, M. Y. & Oskoueian, E. Flavonoid analyses and antimicrobial activity of various parts of Phaleria macrocarpa (Scheff.) Boerl fruit. Int. J. Mol. Sci. 12, 3422-3431 (2011).
9. Zandi, K. et al. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J. 560, 1-11 (2011).
10. Pistelli, L. & Giorgi, I. Antimicrobial properties of flavonoids in Dietary Phytochemicals And Microbes (ed. Patra, A. K.) 33-91 (Springer Netherlands, 2012).
11. Moghaddam, E. et al. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 4, 1-8 (2014).
12. Li, B. W. et al. Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. Bioorgan. Med. Chem. 22, 3146-3158 (2014).
13. Sithisarn, P., Michaelis, M., Schubert-Zsilavecz, M. & Cinatl, J. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus- infected cells. Antiviral Res. 97, 41-48 (2013).
14. Yin, D. et al. Antiviral activity of total flavonoid extracts from Selaginella moellendorffii Hieron against coxsackie virus B3 in vitro and in vivo. Evid. Based Complement Alternat. Med. 2014, 1-7 (2014).
15. Johari, J., Kianmehr, A., Mustafa, M. R., Abubakar, S. & Zandi, K. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int. J. Mol Sci. 13, 16785-16795 (2012).
16. Lani, R. et al. Antiviral activity of silymarin against chikungunya virus. Sci. Rep. 5, 1-10 (2015).
17. Murali, K. S. et al. Anti-chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon. Asian Pac. J. Trop. Med. 8, 352-358 (2015).
18. Renapurkar, D. K. Efficacy of Chloroquine in management of Chikungunya: a phase iv clinical trial study. Int. J. Pharm. Biol. Sci. 2, 407-412 (2011).
19. Samy, G. B. & Xavier, L. Molecular docking studies on antiviral drugs for SARS. Int. J. Adv. Res. Comput. Sci. Softw. Eng. 5, 75-79 (2015).
20. Stark, J. L. & Powers, R. Application of NMR and molecular docking in structure-based drug discovery in NMR Of Proteins And Small Biomolecules (ed. Zhu, G.) 7-17 (Springer Berlin Heidelberg, 2012).
21. Rashad, A. A., Mahalingam, S. & Keller, P. A. Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. J. Med. Chem. 57, 1147-1166 (2014).
22. Nguyen, P. T., Yu, H. & Keller, P. A. Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus. J. Mol. Model. 20, 1-12 (2014).
23. Bora, L. Homology Modeling and Docking to Potential Novel Inhibitor for Chikungunya (37997) Protein nsP2 Protease. J. Proteomics Bioinform. 5, 54-59 (2012).
24. Kumar, P. S. et al. Exploring the polymerase activity of chikungunya viral non structural protein 4(nsP4) using molecular modeling, epharmacophore and docking studies. Int. J. Pharm. Life Sci. 3, 1752-1765 (2012).
25. Jobidhas, D. P. & Joseph, B. Mechanistic Characterization and Designing Possible Molecular Ligand Interactions with RdRp from CHIKV. Int. J. Pharm. Sci. Drug Res. 5, 78-83 (2013).
26. Vidhya, R. V., Nair, A. S., Dhar, P. K. & Nayarisseri, A. Epitope characterization and docking studies on Chikungunya viral Envelope 2 protein. Int. J. Sci. Res. Pub. 5, 1-9 (2015).
27. Karimi, R. Introduction to medicinal chemistry in Biomedical & Pharmaceutical Sciences with Patient Care Correlations (ed. Karimi, R.) 405-406 (Jones & Bartlett Publishers, 2014).
28. William, L. D. Molecular interaction (non-covalent interactions). (2015) Available at: http://www.chemistry.gatech.edu/~lw26/ structure/molecular-interactions/mol-int.html (Accessed: 2nd December 2015).
29. Szatyłowicz, H. Structural aspects of the intermolecular hydrogen bond strength: H-bonded complexes of aniline, phenol and pyridine derivatives. J. Phys. Org. Chem. 21, 897-914 (2008).
30. Copeland, R. A. Enzyme reactions mechanisms in Evaluation Of Enzyme Inhibitors In Drug Discovery: A Guide For Medicinal Chemists And Pharmacologists (ed. Copeland, R. A.) 21-25 (John Wiley & Sons, 2013).
31. Rashad, A. A., Mahalingam, S. & Keller, P. A. Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. J. Med. Chem. 57, 1147-1166 (2014).
32. Ding, Y. et al. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Arch. Virol. 159, 3269-3278 (2014).
33. Li, X. et al. The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro. Viruses. 7, 4756-4771 (2015).
34. Natarajan, A., Sugumar, S., Bitragunta, S. & Balasubramanyan, N. Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes. BMC Complementary Altern. Med. 15, 73 (2015).
35. Qiu, J. X. et al. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies. Drug Des. Dev. Ther. 9, 841 (2015).
36. Meng, X. Y., Zhang, H. X., Mezei, M. & Cui, M. Molecular docking: a powerful approach for structure-based drug discovery. Curr. Comput. Aided Drug Des. 7, 146 (2011).
37. Azam, S. S. & Abbasi, S. W. Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin- O-methyltransferase using different docking routines. Theor. Biol. Med. Model. 10, 63 (2013).
38. Hossain, M. M. et al. Structural analysis and molecular docking of potential ligands with chorismate synthase of Listeria monocytogenes: A novel antibacterial drug target. Indian. J. Biochem. Biophys. 52, 45-59 (2015).